﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>BioImpacts</JournalTitle>
      <Issn>2228-5652</Issn>
      <Volume>2</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2012</Year>
        <Month>03</Month>
        <DAY>30</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Promoters of Cancer Genes for Recombinant Protein Expression in Human Cancer Cell Lines</ArticleTitle>
    <FirstPage>55</FirstPage>
    <LastPage>60</LastPage>
    <ELocationID EIdType="doi">10.5681/bi.2012.007</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Pourhassan-Moghaddam</LastName>
      </Author>
      <Author>
        <FirstName>Behrouz</FirstName>
        <LastName>Farhadi</LastName>
      </Author>
      <Author>
        <FirstName>Kazem</FirstName>
        <LastName>Nejati-Koshki</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.5681/bi.2012.007</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2011</Year>
        <Month>12</Month>
        <Day>27</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2012</Year>
        <Month>02</Month>
        <Day>29</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Production of complex human recombinant proteins is an important issue in medical biotechnology. These proteins are mostly expressed in non-human mammalian host cells. This has some problems including non-human post-translational modifications, application of high-cost agents for inducing protein expression and low yields. Therefore, it is necessary to use new expression systems to overcome the indicated challenges. Methods: In this paper, we hypothesize the application of promoter regions of cancer genes, which have a high rate of transcription in human cancer cell lines, for designing new expression vectors. Results: After designing, these vectors could be applied to produce complex human recombinant proteins in the human cancer cell lines as production hosts. Conclusion: Application of these expression vectors for the production of recombinant human proteins in the human cancer cell lines have some advantages including authentic post-translational modifications, proper-cost of commercialization, and high yields.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Recombinant Protein Expression</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Promoters</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cancer Genes</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Human Cancer Cell Lines</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>